‘No one has been more dedicated to increasing the pipeline of minority scholars...’
The American Society for Biochemistry and Molecular Biology has named Lovell Jones the winner of the society’s Ruth Kirschstein Diversity in Science Award. Jones is a professor at both the University of Texas MD Anderson Cancer Center and the University of Houston as well as director of the joint Center for Health Equity & Evaluation Research.
Throughout his career, Jones has focused on minority health issues. He was a co-founder of the Intercultural Cancer Council, the nation’s largest multicultural health policy group focused on minorities, the medically underserved and cancer; chaired the first Biennial Symposium on Minorities and Cancer in 1987; and was among the leaders who worked with members of Congress to designate the third week of every April National Minority Cancer Awareness Week.
.png)
—Lovell Jones
Thomas Landefeld, professor at California State University–Dominguez Hills, praised Jones for being “totally devoted to diversity issues in the scientific community, with a major emphasis on both addressing the underrepresentation of minorities at all levels in academia, industry and government, as well as the overwhelming issue of health disparities in our nation.”
Jones also has shown great dedication to mentorship of underrepresented groups. In supporting his nomination for the award, Marian Johnson-Thompson, professor emerita of the University of the District of Columbia, cited his “attention to promoting diversity in training programs, which has led to the next generation of health-disparities researchers and policy leaders.” Judith Kaur, from the Mayo Clinic, agreed: “No one has been more dedicated to increasing the pipeline of minority scholars than Lovell Jones.”
In addition to his efforts involving minority health disparities, Jones is also a pre-eminent scientist. He holds both M.S. and Ph.D. degrees in zoology from the University of California, Berkeley, and has worked in the department of biochemistry at MD Anderson since 1980, focusing primarily on the role of estrogen and environmental estrogenic agents in tumor induction in hormonally responsive tissues.
Jones received his award and delivered an award lecture during the Experimental Biology 2012 conference in San Diego.
About the award
The Ruth Kirschstein Diversity in Science Award was established to honor an outstanding scientist who has shown a strong commitment to the encouragement of underrepresented minorities to enter the scientific enterprise and/or to the effective mentorship of those within it. The award consists of a plaque, a cash prize of $3,000 and transportation expenses to present a lecture at the ASBMB annual meeting.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

New mass spectrometry tool accurately identifies bacteria
Scientists develop a software tool to categorize microbe species and antibiotic resistance markers to aid clinical and environmental research. Read about this recent article published in Molecular & Cellular Proteomics.

New tool matches microbial and metabolic metaproteomic data
Scientists develop a bioinformatics program that maps omics data to metabolic pathways. Read about this recent article published in Molecular & Cellular Proteomics

Meet Paul Shapiro
Learn how the JBC associate editor went from milking cows on a dairy farm to analyzing kinases in the lab.

CRISPR epigenome editor offers potential gene therapies
Scientists from the University of California, Berkeley, created a system to modify the methylation patterns in neurons. They presented their findings at ASBMB 2025.

Finding a symphony among complex molecules
MOSAIC scholar Stanna Dorn uses total synthesis to recreate rare bacterial natural products with potential therapeutic applications.

E-cigarettes drive irreversible lung damage via free radicals
E-cigarettes are often thought to be safer because they lack many of the carcinogens found in tobacco cigarettes. However, scientists recently found that exposure to e-cigarette vapor can cause severe, irreversible lung damage.